Crysvita

4,071.0110,926.90

Crysvita (burosumab) is indicated for the treatment of X-linked hypophosphatemia (XLH) and Tumor-induced osteomalacia (TIO).

PATIENTS HELPED

  • Over 1.2 million patients reached

  • More than 11,000 patients helped

  • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
CRYSVITA (BUROSUMAB) Package

1 single-dose vial of 10 mg/mL, 1 single-dose vial of 20 mg/mL, 1 single-dose vial of 30 mg/mL

Reviews

There are no reviews yet.

Be the first to review “Crysvita”

Your email address will not be published. Required fields are marked *

Shopping Cart